Lisa N Cruz1,2, Emily Kline1, Larry J Seidman1, Kyle S Minor1,3, Eric C Meyer1,4,5,6, Carina Iati1, Suzanna V Zimmet1, Michelle Friedman-Yakoobian1. 1. Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 2. Division of Schizophrenia Research, Rutgers University Behavioral Health Care, Piscataway, New Jersey, USA. 3. Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA. 4. VA VISN 17 Center of Excellence for Research on Returning War Veterans, Waco, USA. 5. Central Texas Veterans Healthcare System, Texas A&M University Health Science Center, Temple, Texas, USA. 6. College of Medicine, Texas A&M University Health Science Center, Temple, Texas, USA.
Abstract
AIM: Previous evidence demonstrates that higher treatment satisfaction is strongly associated with improved clinical outcomes and functioning. The aim of the current study is to explore potential associations between clinical and demographic attributes, as well as changes in role, social and cognitive functioning occurring over the course of treatment, on self-reported treatment satisfaction within the context of an intensive first-episode psychosis intervention programme. METHODS: Forty-four young adults attending a first-episode psychosis treatment programme completed a battery of clinical and neuropsychological measures at intake to the programme and again after 6 months of treatment. A modified version of the Client Satisfaction Questionnaire was administered at 6 months. Baseline, 6-month and change scores across the clinical and demographic measures were examined relative to the satisfaction questionnaire to evaluate determinants of treatment satisfaction. RESULTS: Better premorbid adjustment during childhood and early adolescence was associated with higher treatment satisfaction, as did positive changes in clients' cognitive performance and their use of humour as a coping strategy. Clients' use of emotional support as a coping strategy at 6 months was also positively associated with treatment satisfaction. Although clients' social and role functioning improved significantly during the 6-month treatment window, changes in functional outcomes were not significantly associated with treatment satisfaction. CONCLUSIONS: The current study highlights the role of premorbid adjustment and changes in coping and neurocognition as factors influencing treatment satisfaction. Future research designs might be able to more specifically ascertain causal relationships between patient characteristics, treatment components, client satisfaction and clinical effects.
AIM: Previous evidence demonstrates that higher treatment satisfaction is strongly associated with improved clinical outcomes and functioning. The aim of the current study is to explore potential associations between clinical and demographic attributes, as well as changes in role, social and cognitive functioning occurring over the course of treatment, on self-reported treatment satisfaction within the context of an intensive first-episode psychosis intervention programme. METHODS: Forty-four young adults attending a first-episode psychosis treatment programme completed a battery of clinical and neuropsychological measures at intake to the programme and again after 6 months of treatment. A modified version of the Client Satisfaction Questionnaire was administered at 6 months. Baseline, 6-month and change scores across the clinical and demographic measures were examined relative to the satisfaction questionnaire to evaluate determinants of treatment satisfaction. RESULTS: Better premorbid adjustment during childhood and early adolescence was associated with higher treatment satisfaction, as did positive changes in clients' cognitive performance and their use of humour as a coping strategy. Clients' use of emotional support as a coping strategy at 6 months was also positively associated with treatment satisfaction. Although clients' social and role functioning improved significantly during the 6-month treatment window, changes in functional outcomes were not significantly associated with treatment satisfaction. CONCLUSIONS: The current study highlights the role of premorbid adjustment and changes in coping and neurocognition as factors influencing treatment satisfaction. Future research designs might be able to more specifically ascertain causal relationships between patient characteristics, treatment components, client satisfaction and clinical effects.
Authors: Luca Pauselli; Chiara Galletti; Norma Verdolini; Enrico Paolini; Daniela Gallucci; Pierfrancesco Maria Balducci; Francesco Bernardini; Jerome H Kogan; Ruth Shim; Patrizia Moretti; Michael T Compton Journal: Community Ment Health J Date: 2017-11-17
Authors: Corrado Sandini; Daniela Zöller; Maude Schneider; Anjali Tarun; Marco Armando; Barnaby Nelson; Paul G Amminger; Hok Pan Yuen; Connie Markulev; Monica R Schäffer; Nilufar Mossaheb; Monika Schlögelhofer; Stefan Smesny; Ian B Hickie; Gregor Emanuel Berger; Eric Yh Chen; Lieuwe de Haan; Dorien H Nieman; Merete Nordentoft; Anita Riecher-Rössler; Swapna Verma; Andrew Thompson; Alison Ruth Yung; Patrick D McGorry; Dimitri Van De Ville; Stephan Eliez Journal: Elife Date: 2021-09-27 Impact factor: 8.140
Authors: Marta Rapado-Castro; Carmen Moreno; Ana Ruíz-Sancho; Francisco Camino; Celso Arango; Maria Mayoral Journal: J Clin Med Date: 2019-12-02 Impact factor: 4.241
Authors: Antonio Taboada-Vázquez; Ruben Gonzalez-Rodriguez; Manuel Gandoy-Crego; Miguel Clemente Journal: Int J Environ Res Public Health Date: 2021-05-13 Impact factor: 3.390